Cross Country Healthcare, Inc.
NASDAQ:CCRNMedical - Care Facilities
+$0.01 today
- Market cap
- $428.06M
- Beta
- 0.45
- P/E (TTM)
- -4.2
- EPS (TTM)
- -$3.13
Volume 1.78M
Average 0.64M
CCRN Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Cross Country Healthcare, Inc.NASDAQ: CCRN
Common Stock · Q1 FY2026 · quarter ended Mar 2026
Common stock broadly unchanged from a year ago
Common stock stood at $3K at the end of Q1 FY2026, up 0.0% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at -9.1% a year.
Context
- Common stock amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Common stock increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +0.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 3K USD
- Year-over-year change
- +0.0%
- 4-year CAGR
- -6.9%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 3K | +0.0% |
| FY2024 | 2024-12-31 | 3K | -25.0% |
| FY2023 | 2023-12-31 | 4K | +0.0% |
| FY2022 | 2022-12-31 | 4K | +0.0% |
| FY2021 | 2021-12-31 | 4K | — |
Common Stock vs competitors
How CCRN compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +0.0% is the 6th highest of 9, against a peer median of +1.6%.
- Common stock amounts to 0.0% of total assets for CCRN, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
AUNAAuna S.A. | Mar 2026 | PEN 17.39M PEN | +0.0% | -58.1% | 0.2% |
| Mar 2026 | $474K USD | +150.8% | +41.0% | 0.0% | |
| Mar 2026 | $166K USD | -96.0% | +0.2% | 0.0% | |
| Mar 2026 | $65K USD | +3.2% | +5.2% | 0.0% | |
| Mar 2026 | $21K USD | +5.0% | +3.0% | 0.0% | |
| Mar 2026 | $10K USD | +11.1% | +12.6% | 0.0% | |
| Mar 2026 | $6K USD | +0.0% | +0.0% | 0.0% | |
| Mar 2026 | $3K USD | +0.0% | -9.1% | 0.0% | |
MCTACharming Medical Limited Class A Ordinary Shares | Mar 2025 | $1.53K USD | +0.0% | — | 0.0% |
| Peer median (excluding CCRN) | — | +1.6% | +3.0% | 0.0% | |
Competitors are the stored peer set for CCRN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.04M | 3.6M | 17.09M | 81.63M | 108.74M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 498.95M | 659.96M | 388.35M | 242.88M | 175.96M |
| Inventory | 0 | 11.07M | 0 | 0 | 0 |
| Other Current Assets | 638K | 1.04M | 2.03M | 2.64M | 1.33M |
| Total Current Assets | 508.27M | 675.67M | 415.15M | 335M | 293.59M |
| Property, Plant & Equipment (Net) | 23.38M | 22.92M | 29.94M | 31.32M | 29.98M |
| Goodwill | 119.49M | 163.27M | 135.43M | 135.06M | 63.8M |
| Intangible Assets | 48.24M | 44.72M | 54.47M | 42.19M | 27.64M |
| Long-term Investments | 14.67M | 23.78M | 33K | 0 | 14.86M |
| Tax Assets | 11.53M | 7.09M | 5.95M | 8.1M | 0 |
| Other Non-current Assets | 7.23M | 10.39M | 38.34M | 37.58M | 19.08M |
| Total Non-current Assets | 224.54M | 272.17M | 264.16M | 254.25M | 155.36M |
| Total Assets | 732.81M | 947.84M | 679.32M | 589.25M | 448.95M |
| Account Payables | 109.75M | 12.86M | 3.04M | 5.74M | 2.04M |
| Short-term Debt | 8.27M | 0 | 0 | 0 | 0 |
| Tax Payables | 7.31M | 20K | 27.04M | 24.61M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8.86M | 41.02M | 127M | 28.76M | 17.32M |
| Total Current Liabilities | 199.77M | 271.64M | 148.59M | 120.4M | 77.76M |
| Long-term Debt | 176.37M | 148.74M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 190K | 247K | 401K | 566K | 2.52M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 48.1M | 65.12M | 54.27M | 47.54M | 44.7M |
| Total Non-current Liabilities | 235.51M | 218.98M | 57.34M | 49.89M | 48.37M |
| Total Liabilities | 435.28M | 490.62M | 205.92M | 170.29M | 126.13M |
| Common Stock | 4K | 4K | 4K | 3K | 3K |
| Retained Earnings | (22.74M) | 165.73M | 238.36M | 218.06M | 123.21M |
| Accumulated OCI | (1.29M) | (1.39M) | (1.39M) | (1.44M) | (1.56M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 297.53M | 457.22M | 473.39M | 418.96M | 322.82M |
| Total Debt | 195.49M | 157.75M | 5.27M | 3.87M | 2.32M |
| Net Debt | 194.45M | 154.14M | (11.83M) | (77.76M) | (106.42M) |
Cross Country Healthcare, Inc.
NASDAQ:CCRN
Intrinsic Alpha fair value
Locked
Current Price
$13.25
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.